Ibn-Alhaytham Hospital Co (P.S.C) Valuation
Is IBNH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IBNH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate IBNH's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate IBNH's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IBNH?
Other financial metrics that can be useful for relative valuation.
What is IBNH's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | د.أ18.40m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.4x |
Enterprise Value/EBITDA | 71.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does IBNH's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 2.1x | ||
CICO Consulting & Investment Group | 2.1x | n/a | د.أ40.8m |
JTH Gesundheitswelt Chiemgau | 0.4x | n/a | €24.4m |
UNIHEALTH Unihealth Consultancy | 4.5x | n/a | ₹2.0b |
8405 Hang Chi Holdings | 1.2x | n/a | HK$264.0m |
IBNH Ibn-Alhaytham Hospital Co (P.S.C) | 1.6x | n/a | د.أ18.4m |
Price-To-Sales vs Peers: IBNH is good value based on its Price-To-Sales Ratio (1.6x) compared to the peer average (2.1x).
Price to Earnings Ratio vs Industry
How does IBNH's PE Ratio compare vs other companies in the Asian Healthcare Industry?
Price-To-Sales vs Industry: IBNH is good value based on its Price-To-Sales Ratio (1.6x) compared to the Asian Healthcare industry average (1.7x).
Price to Sales Ratio vs Fair Ratio
What is IBNH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.6x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate IBNH's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.